Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002303 · ClinicalTrials.gov registry record · NA
The Safety and Effectiveness of r-HuEPO in Patients With AIDS or Advanced AIDS-Related Complex (ARC) Who Are Anemic
A NA study, sponsored by Ortho Pharmaceuticals.
- Completed
- Registry status
- NA
- Development phase
NCT00002303: Completed NA study, sponsored by Ortho Pharmaceuticals.
NCT00002303 is a NA study that has completed, run by Ortho Pharmaceuticals. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00002303, a NA study, has completed, sponsored by Ortho Pharmaceuticals.
- COMPLETED
- Registry status
- NA
- Development phase
Study Summary
To determine the safety and efficacy of erythropoietin administered to patients with AIDS or advanced AIDS related complex ARC and anemia.
Interventions
- DRUG Epoetin alfa
Trial Details
| Field | Value |
|---|---|
| Phase | NA |
What the finished NCT00002303 record still lists
NCT00002303 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which Epoetin alfa is the first listed.
NCT00002303 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00002303 about?
NCT00002303 is a clinical study titled "The Safety and Effectiveness of r-HuEPO in Patients With AIDS or Advanced AIDS-Related Complex (ARC) Who Are Anemic". To determine the safety and efficacy of erythropoietin administered to patients with AIDS or advanced AIDS related complex ARC and anemia.
What is the current status of trial NCT00002303?
This trial is currently completed. It is a NA study.
What interventions are being tested in trial NCT00002303?
The interventions under investigation include: Epoetin alfa (DRUG).
Who is sponsoring clinical trial NCT00002303?
This trial is sponsored by Ortho Pharmaceuticals, which has 6 total clinical trials registered on ClinicalTrials.gov.